News Search Results
Jun 23, 2025, 10:30 ET Pressure Monitoring Market worth $25.48 billion by 2032 with 8.3% CAGR | MarketsandMarkets™
monitoring devices that enable real-time tracking and remote care. The increasing acceptance of telemedicine and home healthcare, especially following the COVID-19 pandemic, has encouraged patients to use self-monitoring devices. Additionally, continuous innovation from leading market players, supportive government
More news about: MarketsandMarkets
Jun 23, 2025, 10:15 ET Booming Advanced Wound Care Market Forecasted to Hit $14.87 Billion by 2030 with 4.79% CAGR - Exclusive Report by The Research Insights
wound care products in the reimbursement policies is encouraging providers to adopt these products in hospitals and home health care. Furthermore, the COVID-19 pandemic is leading to increased investment in
More news about: The Research Insights
Jun 23, 2025, 10:15 ET Côte d'Ivoire In Vitro Diagnostics Market Set to Grow from USD 21.5 Million to USD 25.8 Million by 2032 - Meticulous Research®
2025 in the overall Côte d'Ivoire IVD market. This market leadership is attributed to the high prevalence of infectious diseases including COVID-19, dengue, malaria, hepatitis, tuberculosis, and HIV, coupled with increasing awareness about diagnostic testing and the growing availability of affordable
More news about: Meticulous Market Research Pvt. Ltd.
Jun 23, 2025, 10:00 ET Anti-Poverty Nonprofit Oyate Group Celebrates Its Five-Year Anniversary
supported is a testament to the importance of this work." Tomas Ramos founded Oyate Group at the onset of the COVID-19 pandemic to address the gaps in critical resources and services for underserved communities in New York City, starting
More news about: Oyate Group
Jun 23, 2025, 09:00 ET Target RWE Advances Next-Generation Causal Inference Approaches in Real-World Evidence with New Publications
Observational Studies of Therapeutics for COVID-19 Infection, addresses the limitations in observational research and propensity score methodologies which historically restrict inference to subpopulations receiving specific treatments - using the COVID-19 pandemic as its setting. "While propensity
More news about: Target RWE
Jun 23, 2025, 06:45 ET Brookdale Comments on ISS Recommendation
including initiatives undertaken to execute on the Company's strategic priorities and their effect on its results; any resurgence or variants of the COVID-19 pandemic; limits on the Company's ability to use net operating loss carryovers to reduce future tax payments; delays in obtaining regulatory approvals;
More news about: Brookdale Senior Living Inc.
Jun 22, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Avis Budget Group, Inc. and Certain Officers - CAR
as it turns out to be in light vehicle costs as well as from a customer acceptance. And we've been doing that." In the years following the Covid-19 pandemic, due to a shortage of fleet supply, automobile rental companies were required to purchase fleet vehicles at higher prices than historic norms.
More news about: Pomerantz LLP
Jun 21, 2025, 18:21 ET Foothill Gold Line Dedicates Four New Metro A Line Stations From Glendora to Pomona
Authority is tremendously grateful to have had these corridor cities by our side, as we navigated the project's construction through the midst of the COVID-19 pandemic, record heat waves, and torrential rainstorms." Each of the four new stations features a center platform with light rail tracks on
More news about: Foothill Gold Line Construction Authority
Jun 21, 2025, 08:40 ET New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine
United States prescribing information and EU Summary of Product Characteristics, with the most common treatment-emergent adverse events being COVID-19 and nasopharyngitis.1 Based on the SUNRISE results, Lundbeck has initiated discussions with relevant regulatory authorities
More news about: H. Lundbeck A/S
Jun 21, 2025, 08:38 ET New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine
United States prescribing information and EU Summary of Product Characteristics, with the most common treatment-emergent adverse events being COVID-19 and nasopharyngitis.1 Based on the SUNRISE results, Lundbeck has initiated discussions with relevant regulatory authorities
More news about: H. Lundbeck A/S
Jun 20, 2025, 16:20 ET NaaS Technology Inc. Received Nasdaq Notification Regarding Minimum Market Value Deficiency
NaaS' ability to protect and enforce its intellectual property rights; NaaS' ability to attract and retain qualified executives and personnel; the COVID-19 pandemic and the effects of government and other measures that have been or will be taken in connection therewith; U.S.-China
More news about: NaaS Technology Inc.
Jun 20, 2025, 10:07 ET Molecular Point-of-Care (mPOC) Market Reaches $1.8 Billion: Kalorama Report Spotlights Rapid PCR Innovation and Expanding Frontiers in STI and HAI Testing
"While the molecular point-of-care market saw unprecedented acceleration during the COVID-19 pandemic, Kalorama's latest analysis reveals it now stands on a firmer foundation with renewed growth expected," said Justin Saeks, senior market
More news about: Kalorama Information
Jun 20, 2025, 09:02 ET MNA: Lawmakers to Examine Legislation to Protect Patients, Nurses, and Healthcare Professionals from Unsafe Staffing, Violence, and Lifting Injuries on June 23 at State House Hearing
at a rate five times that of other professions. In the years during and following the COVID-19 pandemic, this longstanding crisis has grown even more problematic. 69% of nurses in 2025 said workplace violence and abuse
More news about: Massachusetts Nurses Association
Jun 20, 2025, 07:00 ET UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference
forward-looking statements contained in this press release. Important factors that could result in such differences include: the global spread and impact of COVID-19, changes in general economic, business and competitive conditions, the inability to obtain necessary regulatory approvals or to obtain them on acceptable
More news about: UCB
Jun 19, 2025, 14:36 ET Biological Safety Cabinets Market to Reach USD 448.4 Million by 2032, Driven by Rising Biosafety Standards and Research Demand
gene therapy clinical trials, which require stringent contamination control. Additionally, the global rise in vaccine development projects—over 300 COVID-19 vaccine candidates were in development at the pandemic's peak—has further driven the need for advanced BSCs in both public and private sector laboratories.
More news about: Credence Research Inc.
Jun 19, 2025, 11:13 ET Infectious Disease Testing Market Remains Dynamic Amid Post-Pandemic Shifts and New Innovations
into the evolving global market for infectious disease testing through the In Vitro Diagnostics Business Outlook newsletter. Despite the decline in COVID-19 testing, the overall infectious disease diagnostics market remains robust, supported by sustained demand for non-COVID tests and the adoption of next-generation
More news about: Kalorama Information
Jun 19, 2025, 11:00 ET Easing Congestion with a 360° View: VIVOTEK Solution Streamlines Taxi Operations at a Major Japanese Travel Hub
Disney Resort, located just a five-minute walk away. Adding to the strain, inbound tourism surged in Japan after COVID-19, making evening hours—especially after 8 PM—particularly congested. In some cases, buses and taxis were unable to access the station due to heavy traffic
More news about: VIVOTEK Inc.
Jun 19, 2025, 10:29 ET Biodefense Market Size worth $22.8 billion, Globally, by 2030 with 5% CAGR - Exclusive Study by The Research Insights
experienced significant expansion recently due to the rising critical threat posed by emerging infectious diseases. The rapid impact of pandemics such as COVID-19, Ebola, and Monkeypox has shown how diseases can quickly cause healthcare system failures and lead to economic and social disruptions. Current health
More news about: The Research Insights
Jun 19, 2025, 05:30 ET Luxury confronts slowdown amid economic headwinds and market disruptions, while industry resilience and strong fundamentals underpin future prospects
that the €1.5 trillion revenue industry faces its first slowdown since the global financial crisis of 2008-09, excluding the temporary shock of the Covid-19 pandemic. For the personal luxury goods segment, a potent post-pandemic rebound saw the market reach €369 billion in 2023. But this slipped last year
More news about: Bain & Company
Jun 18, 2025, 12:02 ET Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test
commercialized; Lucid's ability to raise additional funding as needed; and other competitive developments. In addition, Lucid continues to monitor the COVID-19 pandemic and the pandemic's impact on Lucid's businesses. These factors are difficult or impossible to predict accurately and many of them are beyond
More news about: Lucid Diagnostics
Jun 18, 2025, 11:11 ET Biobot Analytics Announces New Funding Round Led by Valor Equity Partners; Expands Board of Directors
Massachusetts Institute of Technology, Biobot Analytics pioneered wastewater-based epidemiology in cities. From tracking COVID-19 trends across hundreds of communities to detecting opioid use and other health indicators, Biobot's technology empowers governments and organizations
More news about: Biobot Analytics, Inc.
Jun 18, 2025, 11:00 ET Oligonucleotide Synthesis Market is expected to generate a revenue of USD 5.75 Billion by 2031, Globally, at 10.49% CAGR: Verified Market Research®
next-generation sequencing (NGS), CRISPR, and qPCR, which are witnessing strong adoption across research labs, clinical diagnostics, and biotech firms. The COVID-19 pandemic further catalyzed demand for diagnostic oligos used in RT-PCR test kits, a trend now extended to infectious disease surveillance, oncology
More news about: Verified Market Research
Jun 18, 2025, 10:41 ET Medical Billing Software Market Share Worth $32.18 Billion by 2030 with 10.2% CAGR - Exclusive Study by The Research Insights
reimbursement models acts as a major force that requires advanced automated billing solutions to achieve precise compliance and operational efficiency. The COVID-19 pandemic accelerated telehealth and
More news about: The Research Insights
Jun 18, 2025, 09:53 ET Children's Hospital of Philadelphia Receives Grant to Study Noninvasive Technique for Detecting Malaria Via Breathalyzer
are now using advanced technologies like mass spectrometry to directly analyze VOCs. In 2022, for example, the EUA approved the first breath-based COVID-19 test that identifies virus-associated VOCs, paving the way for similar diagnostic tools for infectious diseases such as malaria. The lab of
More news about: Children's Hospital of Philadelphia
Jun 18, 2025, 09:00 ET AudioCodes Now Certified for Webex Calling Voice Services
of AudioCodes to successfully integrate the products and operations of acquired companies into AudioCodes' business; possible adverse impact of the COVID-19 pandemic on our business and results of operations; the effects of the current terrorist attacks by Hamas in Israel,
More news about: AudioCodes